AecorBio Inc., 2025-11-12
An SEC Form D private-offering notice from Menlo Park, CA, a $2,532,988 filer-stated offering target in Biotech. Filed 2025-11-12. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
AecorBio is an IND stage biopharmaceutical company developing peptide therapeutics that target drug resistance mechanisms in oncology, immunology and neurology, with a lead candidate for castration resistant prostate cancer.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Foxglove Technologies Inc., 2025-11-13, $40M, San Francisco, CA
- Carolina Molecular Inc., 2025-11-13, $1.7M, Morrisville, NC
- OPEN DOORS PARTNERS, LLC, 2025-11-13, $660K, Woodside, CA
- Conexeu Sciences Inc., 2025-11-13, $2.9M, Reno, NV
- Known Co., 2025-11-13, $9.8M, San Francisco, CA
- ELIXIRGEN THERAPEUTICS, INC., 2025-11-13, $4M, Baltimore, MD
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.